ADAR1 Capital Management »

Replimune Group shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Replimune Group (REPL) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Replimune Group

Tip: Access up to 7 years of quarterly data

All positions including Replimune Group held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Replimune Group by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.3M 1.0M 4.19
2025-06-30 $97k 10k 9.29

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Keros Therapeutics (KROS)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Immunovant (IMVT)
89bio (ETNB)
Zai Lab Adr (ZLAB)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Uniqure Nv SHS (QURE)
Prothena Corp SHS (PRTA)
Bridgebio Pharma (BBIO)
Arbutus Biopharma (ABUS)

View all positions for ADAR1 Capital Management

Top funds holding Replimune Group

Baker Bros. Advisors
Rtw Investments
BlackRock
Fcpm Iii Services B.v.
Point72 Asset Management
Ally Bridge Group
Susquehanna International
Vanguard Group
Tang Capital Management
State Street Corporation
Braidwell
Balyasny Asset Management
Readystate Asset Management
Millennium Management
Geode Capital Management

View all funds holding Replimune Group